<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Kim DH</submitter><pubmed_abstract>&lt;b>Background and objective:&lt;/b> The aim was to evaluate the clinical significance of prominent fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) on the prognosis of mild acute ischemic stroke with middle cerebral artery (MCA) occlusion. &lt;b>Methods:&lt;/b> We recruited consecutive stroke patients with initial National Institutes of Health Stroke Scale (NIHSS) scores ≤5 and MCA occlusion on magnetic resonance angiography within 24 h of stroke onset. Prominent distal FVH was defined as an extension to more than one-third of the MCA territory. We compared clinical outcomes between prominent and non-prominent FVH groups in patients who had and had not received reperfusion therapy. &lt;b>Results:&lt;/b> Of 112 participants [43 women; median age, 67 years [Interquartile range, 54-</pubmed_abstract><journal>Frontiers in neurology</journal><pagination>722</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6614286</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prominent FLAIR Vascular Hyperintensity Is a Predictor of Unfavorable Outcomes in Non-thrombolysed Ischemic Stroke Patients With Mild Symptoms and Large Artery Occlusion.</pubmed_title><pmcid>PMC6614286</pmcid><pubmed_authors>Kim DH</pubmed_authors><pubmed_authors>Lee YK</pubmed_authors><pubmed_authors>Cha JK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prominent FLAIR Vascular Hyperintensity Is a Predictor of Unfavorable Outcomes in Non-thrombolysed Ischemic Stroke Patients With Mild Symptoms and Large Artery Occlusion.</name><description>&lt;b>Background and objective:&lt;/b> The aim was to evaluate the clinical significance of prominent fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH) on the prognosis of mild acute ischemic stroke with middle cerebral artery (MCA) occlusion. &lt;b>Methods:&lt;/b> We recruited consecutive stroke patients with initial National Institutes of Health Stroke Scale (NIHSS) scores ≤5 and MCA occlusion on magnetic resonance angiography within 24 h of stroke onset. Prominent distal FVH was defined as an extension to more than one-third of the MCA territory. We compared clinical outcomes between prominent and non-prominent FVH groups in patients who had and had not received reperfusion therapy. &lt;b>Results:&lt;/b> Of 112 participants [43 women; median age, 67 years [Interquartile range, 54-</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-19T17:29:13.103Z</modification><creation>2019-07-25T07:06:25Z</creation></dates><accession>S-EPMC6614286</accession><cross_references><pubmed>31312181</pubmed><doi>10.3389/fneur.2019.00722</doi></cross_references></HashMap>